HOOKIPA PHARMA INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/cc263619-7bc2-4afe-8c52-9b0a7e48b715/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-51.5M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-001853 |
| FY 2023 | $-97.7M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-003738 |
| FY 2022 | $-73.2M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003778 |
| FY 2021 | $-81.7M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004211 |
| FY 2020 | $-53.3M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-003176 |
| FY 2019 | $-51.1M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002928 |
| FY 2018 | $-21.2M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002928 |
| FY 2017 | $-14.2M | 2017-01-01 – 2017-12-31 | evidence 0001558370-20-002928 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).